The formerly NZX-listed medicinal cannabis firm was placed into receivership by its noteholders in May.
While 10% reflects the long-term historic returns of the US sharemarket, stocks today are much more expensive.
Both parties are feeling some pain.
Carry on: Business travel news includes more retro livery and Airbus widebodies in China.
New book by economists Julie Fry and Hayden Glass challenges assumptions on Kiwis' ambition.
The global company requires regulatory approval.
'They’re basically admitting the [EU] economy is quite soft,' analysts say.
Successive governments have burdened health boards with boneheaded financial engineering.
Crown entity's work means delayed projects progressing by as much as 20 years.
Construction industry woes not impacting rail project, select committee told.